Adalimumab/infliximabHerpes simplex encephalitis: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2009年 / 1282卷 / 1期

关键词：

Infliximab; Herpes Simplex Virus; Adalimumab; Cefotaxime; Psoriatic Arthritis;

D O I：

10.2165/00128415-200912820-00027

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：8 / 8

相关论文

共 50 条

[21] Adalimumab/infliximabVarious toxities: 3 case reports
Reactions Weekly, 2018, 1702 (1) : 16 - 16
[22] Adalimumab/infliximabMiliary tuberculosis: 3 case reports
Reactions Weekly, 2012, 1422 (1) : 7 - 7
[23] Adalimumab/etanercept/methotrexateSarcoidosis: 3 case reports
Reactions Weekly, 2012, 1396 (1) : 6 - 6
[24] Adalimumab/etanerceptAutoimmune renal disorders: 3 case reports
Reactions Weekly, 2014, 1528 (1) : 16 - 16
[25] Abatacept/adalimumab/methotrexateVarious toxicities: 3 case reports
Reactions Weekly, 2015, 1557 (1) : 13 - 13
[26] Adalimumab/etanercept/infliximabReactivation of tuberculosis: 3 case reports
Reactions Weekly, 2012, 1410 (1) : 5 - 5
[27] Adalimumab/infliximabAmicrobial pustulosis of the folds: 3 case reports
Reactions Weekly, 2015, 1582 (1) : 20 - 20
[28] Adalimumab/etanercept/infliximabVarious toxicities: 3 case reports
Reactions Weekly, 2024, 2027 (1) : 20 - 20
[29] Adalimumab/infliximabDermatological side effects: 3 case reports
Reactions Weekly, 2017, 1633 (1) : 24 - 24
[30] Adalimumab/etanerceptMyositis, polymyositis and dermatomyositis: 3 case reports
Reactions Weekly, 2016, 1586 (1) : 24 - 24

← 1 2 3 4 5 →